Cargando…
Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
Parkinson’s disease (PD) is the second most common neurodegenerative disease in the world. The diagnosis of PD is based on movement dysfunctions. Many patients also suffer from comorbid depression in spite of adequate treatment with dopamine replacement, indicating that also other non-dopaminergic m...
Autores principales: | Svenningsson, Per, Pålhagen, Sven, Mathé, Aleksander A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466951/ https://www.ncbi.nlm.nih.gov/pubmed/28659833 http://dx.doi.org/10.3389/fpsyt.2017.00102 |
Ejemplares similares
-
Cerebrospinal Fluid Neuropeptide Y Levels in Major Depression and Reported Childhood Trauma
por: Soleimani, Laili, et al.
Publicado: (2014) -
Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson’s Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task
por: Herzallah, Mohammad M., et al.
Publicado: (2017) -
A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
por: Mathé, Aleksander A, et al.
Publicado: (2020) -
Neuropeptide y and neuropeptide s in major depressive disorder and post-traumatic stress disorder: Preclinical andclinical studies
por: Mathe, A.
Publicado: (2021) -
Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
por: Madeira, Caroline, et al.
Publicado: (2018)